Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
irbesartan, Quantity: 75 mg
Medis Pharma Pty Ltd
Irbesartan
Tablet, film coated
Excipient Ingredients: lactose monohydrate; croscarmellose sodium; magnesium stearate; povidone; titanium dioxide; hypromellose; macrogol 4000
Oral
30s
(S4) Prescription Only Medicine
Irbesartan is indicated for the following: For the treatment of hypertension. For delaying the progression of renal disease in hypertensive type II diabetics with persistent micro-albuminuria (equal to or greater than 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.
Visual Identification: White to off-white, oval shaped, biconvex, film coated tablet, debossed with "L172" on one side and "75" on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2012-11-13